App pplicat lications ions of of MR MRI I to to AKI Evidence - - PowerPoint PPT Presentation

app pplicat lications ions of of mr mri i to to aki
SMART_READER_LITE
LIVE PREVIEW

App pplicat lications ions of of MR MRI I to to AKI Evidence - - PowerPoint PPT Presentation

App pplicat lications ions of of MR MRI I to to AKI Evidence to date Andrea Fekete associate professor Notthingham, October, 2019, supported by PARENCHYMA COST Association FACULTY OF MEDICINE I. Department of Pediatrics Diagnosis of


slide-1
SLIDE 1
  • I. Department of Pediatrics

FACULTY OF MEDICINE

Andrea Fekete associate professor

App pplicat lications ions of

  • f MR

MRI I to to AKI

Evidence to date

Notthingham, October, 2019, supported by PARENCHYMA COST Association

slide-2
SLIDE 2

ÁLTALÁNOS ORVOSTUDOMÁNYI KAR

Szervezeti egység megnevezése – ha hosszabb a név, két sorba tördelve

Diagnosis of AKI

Based on: Serum um cr creati tinin nine and urine ne output tput

Increase in Serum Cr by 0.3 mg/dl within 48 hours OR Increase in Serum Cr to 1.5 times of baseline, within the prior 7 days OR Urine volume <0.5 ml/kg/h for 6 hours.

KDIGO Acute Kidney Injury Work Group. Kidney Int. 2012

slide-3
SLIDE 3

Application of MRI to AKI Notthingham, 2019 Andrea Fekete

Di Diag agnos nosis is of

  • f AK

AKI

Based on: serum rum creatinine tinine increase ease and/or

  • r decrease

ease in urin rine e output put

BU BUT NO NOT sensitiv ensitive, , specif cific, ic, rap apid d EN ENOUG OUGH H

CONSTANT ANT NEED D new bio iomarker ers, non-in invasiv sive, , im imagi ging tec echn hniq iques ues

slide-4
SLIDE 4

Application of MRI to AKI Notthingham, 2019 Andrea Fekete

Con

  • ntr

trast ast in indu duced ed AK AKI (C I (CIA IAKI) KI)

  • 3rd leading cause of AKI in hospitalized

patients (11% incidence)

  • Long-term consequences, high mortality
  • Underdiagnosed in many cases – no marker
  • Risk factors:
  • dosage, frequency and route of administration
  • type of contrast agent
  • comorbidities, hydration status etc.
slide-5
SLIDE 5

Application of MRI to AKI Notthingham, 2019 Andrea Fekete

Why fMRI RI in inst stea ead of SeC eCr?

  • Model: adult male Wistar rats,

ionic iodinated CA (6 ml/bwkg, iv.)

  • Time points: Baseline, 30 min, 12h, 24h, 48h, 72h,96h
  • Methods: 3T GE BOLD, ASL, SeCrea

Chen et al, 2015

ASL Bold

slide-6
SLIDE 6

A S L B O L D

RBF and oxygen level decrease in outer medulla and cortex.

Chen et al, 2015

𝑆2 ∗ value of pre- and postinjection of CM (mean ± SD; Hz). *vs. Baseline

slide-7
SLIDE 7

A S L B O L D

ASL and BOL OLD ar are more e sensi nsitiv tive than than Crea ea to to renal al injur ury. .

RBF and oxygen level decrease in

  • uter medulla and

cortex.

slide-8
SLIDE 8

Application of MRI to AKI Notthingham, 2019 Andrea Fekete

Hi Higher er do dose se, , hig igher er in incid iden ence?

  • Model: adult, male New Zealand rabbits

iohexol (1, 2.5, 5.0 gL/bwkg, iv.)

Wang al, 2019

  • Time points: Baseline, 1h, 24h, 48h, 72h,96h
  • Methods: 3T GE , SeCrea, uNGAL, histology, VEGF, HIF-1 IHC

cortex (CO), outer stripe of outer medulla (OSOM), inner stripe of outer medulla (ISOM), and inner medulla(IM)

T2

R2*ROI ADC ROI Hematoxylin-eosin

slide-9
SLIDE 9
  • CA iohexol cause a dose

and time-dependent response in renal hypoxia.

  • Cortical BOLD and ASL

values correlates with NGAL, HIF-1, VEGF expression indicating massive tubular injury.

  • Medullary hypoxia is typical

in CIAKI.

Wang al, 2019

slide-10
SLIDE 10
  • 1. CA iohexol cause a dose

and time-dependent response in renal hypoxia.

  • 2. Cortical BOLD and ASL

values correlates with NGAL, HIF-1, VEGF expression indicating massive tubular injury.

  • 3. Medullary hypoxia is

typical in CIAKI.

uNGAL AL combi mbined wit ith fMRI is is the ea earlie iest indi dicator

  • r of

ren enal hypoxi xic in inju jury casued ed by by CIAKI KI in in a a CA do dose- de depe pende dent manner er.

Wang al, 2019

slide-11
SLIDE 11

Application of MRI to AKI Notthingham, 2019 Andrea Fekete

Hi Higher er freq eque uenc ncy, , hig igher er in inci cide denc nce?

  • Model: adult, male Wistar rats

iodine (4.0 gL/bwkg, iv. 1x, 2x, 1-3-5d)

Wang al, 2018

  • Time points: Baseline, 1h, 1d, 3d, 5d, 10d
  • Methods: 3T GE , SeCrea, uNGAL, histology, HIF-1 IHC

cortex (CO), outer stripe of outer medulla (OSOM), inner stripe of outer medulla (ISOM), and inner medulla(IM)

Native T2

R2*ROI

slide-12
SLIDE 12

Wang al, 2018

  • 1. Inner stripe of the outer

medulla is the most sensitive to renal hypoxia.

  • 2. Repeated iodaxol treament

results in increased reduction of oxygen tension and hypoperfusion.

HIF-1 alpha in ISOP

slide-13
SLIDE 13

Wang al, 2018

  • 1. Inner stripe of the outer medulla is

the most sensitive to renal hypoxia.

  • 2. Repeated iodaxol treament results

in increased reduction of oxygen tension and hypoperfusion.

Repetitive CA injections within a short-term face higher-risk of CIAKI and a long-term loss

  • f kidney function.
slide-14
SLIDE 14

Application of MRI to AKI Notthingham, 2019 Andrea Fekete

fMRI RI for

  • r per

erfusio usion in in A AKI KI?

  • Model: adult, male Wistar rats,
  • 50 min warm ischemia

Ritt, et al 2009; Zimmer et al, 2013

  • Time points: contralateral baseline, 5d
  • Methods: 3T GE ASL , DCE, histology
slide-15
SLIDE 15

Application of MRI to AKI Notthingham, 2019 Andrea Fekete

fMRI RI for

  • r per

erfusio usion in in A AKI KI?

  • Model: adult, male Wistar rats,
  • 50 min warm ischemia

Zimmer et al, 2013

  • Time points: contralateral baseline, 5d
  • Methods: 3T GE ASL , DCE, histology

ASL is a sensitive and reproducible marker

  • f renal perfusion in AKI.
slide-16
SLIDE 16

Application of MRI to AKI Notthingham, 2019 Andrea Fekete

fMRI RI for

  • r per

erfusio usion in in A AKI KI?

  • Model: adult, male mice,
  • mild (35min) or severe (45 min) unilateral ischemia
  • Different strains C57/B6 vs. Sv
  • Time points: Baseline, 1d, 7d, 28d
  • Methods: 7T GE ASL, PAH- renal plasma flow, inulin- GFR,

histology (Masson), collagen- expression

Hueper et al, 2013, Tewes et al, 2017

slide-17
SLIDE 17

Hueper et al, 2013, Tewes et al, 2017

  • Kidney volume and renal perfusion were

decreased after AKI (measured by T2- weighted and ASL resp).

  • Contralateral kidney-size increased and

hyperfiltration were observed as a compensatory mechanism.

slide-18
SLIDE 18

Hueper et al, 2013, Tewes et al, 2017

  • Perfusion measured by ASL at d7, d14 is significantly correlated to

kidney volume and structural renal damage at d28.

slide-19
SLIDE 19

Hueper et al, 2013, Tewes et al, 2017

Renal perfusion measured by ASL might be an early and non-invasive tool in the prediction of long-term outcomes after AKI.

slide-20
SLIDE 20

Application of MRI to AKI Notthingham, 2019 Andrea Fekete

fMRI RI for

  • r in

inflam ammat mation ion in in A AKI KI?

  • Model: C57BL/6JHan-ztm (H2b) (B6) and female BALB/c

JHan-ztm (H2d) (BALB/c) mice

  • Fully mismatched allogenic kidney transplantation
  • Isogenic kidney transplantation
  • Time points: Baseline, 1d, 7d
  • Methods: 7T GE DWI, histology (Banff-criteria), IHC, FACS

Hueper et al, 2016

slide-21
SLIDE 21

Hueper et al, 2016

ADC was decreased only in isogenic group reflecting inflammation, while T2-increase, indicating tissue edema, was present in both Tx groups.

Isogeni nic Allogeni nic

slide-22
SLIDE 22

Hueper et al, 2016

DWI I val alid id for det etecti ecting ng infla lamma mmation tion, , edema ema an and tu tubu bular lar functi ction

  • n an

and differentiat erentiate bet between en ac acute rejection ection and ac acute tubu bular lar necr ecrosis

  • sis.
slide-23
SLIDE 23

Application of MRI to AKI Notthingham, 2019 Andrea Fekete

Conclusion nclusion

  • Preclin fMRI can answer some questions that

clinical studies can not .

  • BOLD, ASL and DWI are promising tools in the

diagnosis and follow-up of AKI.

  • Improvement in the hardware, postprocessing

and validation is essential for clinical use. fMR MRI co comb mbined ined wi with th exi xisting ting bi bioma marker ers is the the mo most t optim imal at at the the mo momen ment.